Intellectual property in the era of COVID-19
Much of the conversation surrounding the COVID-19 pandemic in recent months has focused on access to vaccines – specifically, vaccine accesses in low- and middle-income countries. But to what extent is re-examining intellectual property (IP) rights part of the solution? As Health Issues India reported in May, “patent waivers for COVID-19 vaccines have been offered […]
Intellectual property in the era of COVID-19 Read More »